Several forms of synaptic modulation in the central nervous system involve changes in the sensitivity of neurotransmitter receptors, due either to an alteration in their numbers or to a change in the affinity of the receptor for its neurotransmitter (1). In both cases, the molecular mechanisms underlying the observed changes are still poorly understood. Studies of various experimental models (2, 3) suggest that, as a general rule, the neurotransmitter regulates its own receptors on target cells by an up or down regulation similar to that proposed for hormonal systems (4). In some systems, such regulation has been shown to involve the synthesis of new receptor molecules (5, 6), whereas in other cases it has been suggested that the regulation depends upon the existence of receptors with different affinities for the neurotransmitter (7). However, the precise succession of events leading from the triggering mechanisms to the changes in receptors is still a matter of speculation.
without changing their affinity for glutamate. Preincubation of the membranes with glutamate does not protect the glutamate "receptors" from the suppressive effects of these agents. The proteases trypsin and a-chymotrypsin increase the maximum number of [3H]glutamate binding sites. The effects of calcium on glutamate binding are different across brain regions. Cerebellar membranes are almost insensitive whereas hippocampal and striatal membranes exhibit a strong increase in the number of binding sites after exposure to even low concentrations of calcium. These results suggest that an endogenous membrane-associated thiol protease regulates the number of [3H~glutamate binding sites in hippocampal membranes and that this is the mechanism by which calcium stimulates glutamate binding. The possibility is discussed that the postulated mechanisms participate in synaptic physiology and in particular may be related to the long-term potentiation of transmission found in hippocampus under certain conditions. Several forms of synaptic modulation in the central nervous system involve changes in the sensitivity of neurotransmitter receptors, due either to an alteration in their numbers or to a change in the affinity of the receptor for its neurotransmitter (1) . In both cases, the molecular mechanisms underlying the observed changes are still poorly understood. Studies of various experimental models (2, 3) suggest that, as a general rule, the neurotransmitter regulates its own receptors on target cells by an up or down regulation similar to that proposed for hormonal systems (4) . In some systems, such regulation has been shown to involve the synthesis of new receptor molecules (5, 6) , whereas in other cases it has been suggested that the regulation depends upon the existence of receptors with different affinities for the neurotransmitter (7) . However, the precise succession of events leading from the triggering mechanisms to the changes in receptors is still a matter of speculation.
We have reported (8) that glutamate "receptors" in hippocampal membranes constitute a class of neurotransmitter receptors that can be regulated. A number of studies indicate that glutamate is likely to be an important excitatory neurotransmitter in the central nervous system (9). Roberts (10) and Foster and Roberts (11) (8) . Because this stimulatory effect persists after removal of the cation, we suggested that such calcium-induced changes in receptor number might account for the functional plasticity exhibited by hippocampal synapses after brief bursts of repetitive electrical stimulation (13) . This hypothesis is consistent with the fact that the long-term potentiation of synaptic transmission that follows such stimulation is quite sensitive to the calcium concentration bathing the brain tissue (14) .
In the present study, we further analyzed the characteristics of the calcium-induced increase in [3H]glutamate binding in hippocampal membranes. We report here that both [3H]glutamate binding and the calcium-stimulating effect are temperature sensitive and are inhibited by the thiol reagent Nethylmaleimide (MalNEt) as well as by various protease inhibitors. Taken together, these data suggest a possible cellular mechanism by which activity at hippocampal synapses might regulate the number of glutamate receptors and thus achieve long-lasting functional change.
MATERIALS AND METHODS

Chemicals. L-[3H]
Glutamic acid was purchased from New England Nuclear (43 Ci/mmol; 1 Ci = 3.7 X 1010 becquerels). MalNEt, tosylamide-2-phenylethyl chloromethyl ketone (TPCK), tosylamide-2-lysine chloromethyl ketone (TLCK), and tosyl-l-arginine methyl ester (TAME) were purchased from Sigma.
Preparation of Membranes from Rat Brain Tissue. Membranes were prepared according to the procedure of Enna and Snyder (15) . Sprague-Dawley rats (150-250 g) were sacrificed by decapitation, the brain was rapidly dissected on ice, and the hippocampus (or other brain areas) was homogenized in 20 vol of cold 0.32 M sucrose by using a glass/Teflon homogenizer (700 rpm, 10 strokes). The homogenate was centrifuged at 1000 X g for 10 min and the supernatant was diluted 1:5 with 0.32 M sucrose and recentrifuged at 14,000 X g for 20 min. The P2 fraction was resuspended in 4 ml of cold distilled water and, after 40 min, the suspension was centrifuged at 7000 X g for 20 min. The supernatant was decanted and the pellet was gently washed with cold distilled water in order to collect only the upper layer. This suspension was centrifuged at 40,000 X g for 30 min and the supernatant was discarded. The pellet was resuspended by sonication (10 sec) in cold distilled water and after dilution with distilled water recentrifuged at 40,000 X g Abbreviations: MaINEt, N-ethylmaleimide; TPCK, tosylamide-2-phenylethyl chloromethyl ketone; TLCK, tosylamide-2-lysine chloromethyl ketone; TAME, tosyl-l-arginine methyl ester.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 (17, 18) , also blocked the Na-independent [3H]glutamate binding. Moreover, several arguments show that these binding sites are totally distinguishable from the sites involved in the high-affinity uptake process of glutamate which, like the Na-dependent y-aminobutyric acid-binding sites (15) , require the presence of sodium. In addition, unilateral hippocampal aspiration did not result in decreased [3H]glutamate binding in the contralateral side, whereas the high-affinity uptake by homogenate was decreased by 30%, excluding the possibility of a mainly presynaptic localization of the binding site. Thus, the characteristics of Na-independent [3H]glutamate binding in hippocampal membranes are similar to those reported for cerebellar membranes (11) (25), who showed that the inhibitors label the catalytic subunit of the cyclic AMP-dependent protein kinase. However, TAME and bacitracin are also potent protease inhibitors and these compounds do not appear to act as alkylating agents. It should also be emphasized that the protease inhibitors are without effect at 40C, when enzymatic activity, but not alkylation, presumably would be greatly decreased, and that these compounds decrease the number of binding sites without influencing their affinity for glutamate. In addition, the inhibitory effects of the protease inhibitors are not modified by preincubation of the membranes with glutamate. Taken together, these data suggest that the inhibitors are not interacting directly with the binding sites but instead are acting on an enzymatic process that regulates the number of sites. This conclusion receives further support from the experiments showing that exogenous proteases produce a modest but readily detected increase in the number of glutamate binding sites. Trypsin and a-chymotrypsin are both serine proteases and their active sites are labeled by TLCK and TPCK, respectively.
The rapid appearance of glutamate receptors is not entirely without precedent and, in particular, it has been shown that the plant lectin concanavalin A induces the appearance of glutamate receptors on molluscan neurons (26) . It is of interest in this regard that several of the cellular effects of concanavalin A are known to be blocked by protease inhibitors at concentrations used in our studies (27) . The hypothesis that thiol proteases may be involved in the regulation of receptors has been also advanced with regard to uterine estradiol receptors (28, 29) .
We have previously reported (8) that low levels of calcium (10-100 MM) increase the number of glutamate binding sites in hippocampal membranes, and the present results suggest that this is due to an action of calcium on the mechanisms discussed above. Glutamate binding sites with similar pharmacological and kinetic properties are found throughout the nervous system, but the effects of calcium are regionally specific. This suggests that calcium influences the number of binding sites not by a direct action on these sites but instead by acting on a process that is present in some brain regions but not in others. Several lines of evidence indicate that this process may be related to the postulated thiol protease. Low concentrations of MalNEt totally block the stimulatory effect of calcium but only slightly decrease the basal number of sites, and the various protease inhibitors eliminate the effect of calcium on glutamate binding.
Our results may be related to the extraordinary long-term potentiation of synaptic transmission found in hippocampal synapses after brief periods of high-frequency stimulation. It is possible that the known calcium influx into the target dendrites (30, 31) produces an increased intracellular calcium concentration which in turn, directly or indirectly, activates a protease and thus uncovers additional glutamate receptors. Although intracellular Ca2+ concentrations are generally supposed to be strictly in the range 0.1-10 ,uM, it is not unlikely that higher local concentrations might be reached, especially after repetitive electrical stimulation. This would produce an increase in synaptic efficacy that presumably would last for the life of the receptors. This hypothesis is in agreement with the observation that the induction of long-term potentiation in hippocampal slices is accompanied by a long-lasting increase in [3H]glutamate binding by the slices* and by an increased number of [3H]glutamate binding sites in membranes prepared from stimulated slices (unpublished data).
The discovery that the effects of calcium on glutamate binding are much more pronounced in some brain regions than others is surprising and potentially quite significant. It should be of some help in isolating the mechanism responsible for calcium's actions because this mechanism is presumably not present in areas such as the cerebellum. It also provides a means of testing the hypothesis that the calcium-activated process observed in the membrane preparations is linked to production of long-term synaptic facilitation-i.e., we would expect that effects resembling long-term potentiation would be readily obtained in cortex but not in cerebellum. Finally, and to the extent that the results described above are related to synaptic physiology, the regional distribution of calcium's effects raises the possibility that different areas of the brain possess varying degrees of synaptic plasticity, or at least of one form of synaptic plasticity.
In any event, the present findings suggest a mechanism for the regulation of receptors in the central nervous system and provide a possible explanation not only for long-term potentiation but also for various experimentally or pathologically induced changes in the operation of synaptic systems.
